首页> 外国专利> Agents for suppressing Neurological Symptoms caused by Peripheral nervous disorder induced by anticancer agents

Agents for suppressing Neurological Symptoms caused by Peripheral nervous disorder induced by anticancer agents

机译:抑制由抗癌药引起的周围神经疾病引起的神经系统症状的药物

摘要

Claim 1: a preparation for inhibiting peripheral nerve disorders caused by anticancer substances, which is characterized by comprising a compound represented by formula (1), wherein R is a liquefied carbide group with a selective alternative, (2) A group of aromatic compounds with alternative substitutes, (3) a heterocycle group with alternative substitutes, (4) a group with formula representative: - or1, wherein R1 is a hydrogen atom, or a propylene group with alternative substitutes,O (5) a group represented by R-N (r1b) (r1c) formula, in which r1b and r1c are the same or different, each group is a hydrogen atom or a liquefied carbide group with alternative substitutes, R0 is a hydrogen atom or a liquefied carbide group, or R and R0 can be combined to form a link, Ring A1 is an optional alternative to ring a, consisting of 1 to 4 alternatives selected from the group, including (I) a liquefied hydrogen carbon group with alternatives and (two) an aromatic hydrocarbon group with alternatives,(III) a formula group: - R11, wherein R11 is a hydrogen atom or a liquefied carbide group of alternative products; and (4) a halogenated atom and (IV) a hydrogen halide atom, AR is an aromatic group of alternative products, and a formula group (2),This is a group represented by formula (3) or (4), n is a whole, from 1 to 4, or a salt or a sample, or a compound represented by formula (5), wherein R1 'is a liquefied carbide group, which can be replaced optionally, (2) an aromatic hydrocarbon group, which can be replaced optionally, (3) An alternative heterocyclic group, (4) a group represented by the formula: - or1a 'where R1a' is a hydrogen atom or a liquefied carbide group, alternative,O (5) is a group consisting of the following formula: n (r1b) (r1c '), where r1b' and r1c 'are equal or different, each of which is a hydrogen atom or a liquefied carbide group with a selective substitute, X is a methylene, NH, a sulfur atom or an oxygen atom, A-ring A1 is a ring composed of 5 to 8 members. One to four substitutes selected from this group can be selected, including (1) an propylene carbide group with substitutes, and (2) an aromatic hydrocarbon group. Succedaneum(III) a formula group: - R2 'in which R2' is a hydrogen atom or an alternative liquefied carbide group, and (4) a halogenated atom, and (IV) a halogenated atom, AR 'is an aromatic hydrocarbon group, alternative, The group represented by the formula (6) is the group represented by the formula (7) or (8),S is an integer 0 to 2, t is an integer 1 to 3, and the total number of S and t is 4 or less; if x is methylene, then y should be an alternative methylene, or a salt or a preamble.
机译:权利要求1:一种用于抑制由抗癌物质引起的周围神经疾病的制剂,其特征在于包含由式(1)表示的化合物,其中R是具有选择性选择的液化碳化物基团,(2)具有以下特征的芳族化合物基团: (3)具有替代取代基的杂环基,(4)具有以下化学式代表的基团:-or1,其中R1是氢原子,或具有取代基的丙烯基,O(5)由RN表示的基团( r1b)(r1c)式,其中r1b和r1c相同或不同,每个基团是氢原子或可替代的液化碳化物基团,R0是氢原子或液化碳化物基团,或者R和R0可以是结合成一个环,A1环是a环的一个可选替代基,由1-4个选自以下组的替代基组成,包括(I)液化氢碳基和(两个)芳香烃基和交替基(III)式基团:-R 11,其中R 11是氢原子或替代产品的液化碳化物基团; (4)卤化原子,(IV)卤化氢原子,AR为替代物的芳香族基团,且为式(2),是式(3)或(4)表示的基团,n为整体为1至4,或为盐或样品,或为式(5)表示的化合物,其中R 1'为可任选取代的液化碳化物基团,(2)为芳族烃基, (3)可选的杂环基团,(4)下式表示的基团:-or1a'其中R1a'为氢原子或液化的碳化物基团,可选地,O(5)为由以下基团组成的基团:下式:n(r1b)(r1c'),其中r1b'和r1c'相同或不同,各自为氢原子或具有选择性取代基的液化碳化物基团,X为亚甲基,NH,硫原子A-环A1是氧原子或氧原子,是由5至8个成员组成的环。可以选择选自该组的1-4个取代基,包括(1)带有取代基的碳化丙烯基,和(2)芳族烃基。仲(III)式基团:-R 2',其中R 2'是氢原子或替代的液化碳化物基团,和(4)卤原子,和(IV)卤原子,AR'是芳族烃基,可选地,由式(6)表示的基团为由式(7)或(8)表示的基团,S为0至2的整数,t为1至3的整数,并且S和t的总数4以下如果x是亚甲基,则y应该是替代的亚甲基,盐或序言。

著录项

  • 公开/公告号AR080024A1

    专利类型

  • 公开/公告日2012-03-07

    原文格式PDF

  • 申请/专利权人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;

    申请/专利号AR2011P100247

  • 发明设计人 KITAMOTO NAOMI;

    申请日2011-01-26

  • 分类号C07D249/04;C07D257/04;C07D275/04;C07D309/28;C07C311/21;A61K31/4192;A61K31/41;A61K31/428;A61K31/351;A61K31/18;A61P25/02;

  • 国家 AR

  • 入库时间 2022-08-21 17:25:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号